LGCCX | RWIAX | LGCCX / RWIAX | |
Total Expense Ratio | 1.65 | 1.51 | 109% |
Annual Report Gross Expense Ratio | 2.47 | 1.51 | 164% |
Fund Existence | 9 years | 23 years | - |
Gain YTD | 17.479 | 18.205 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 250 | 600% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 308M | 140B | 0% |
Annual Yield % from dividends | 0.00 | 0.80 | - |
Returns for 1 year | 15.79 | 8.57 | 184% |
Returns for 3 years | 80.67 | 66.28 | 122% |
Returns for 5 years | 58.52 | 50.69 | 115% |
Returns for 10 years | N/A | 84.57 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 39.57 | 0.43 | +1.10% |
Eventide Healthcare & Life Sciences A | |||
FCVIX | 20.26 | 0.20 | +1.00% |
Fidelity Advisor Small Cap Value I | |||
GMVIX | 16.91 | 0.16 | +0.96% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
WSHCX | 65.48 | 0.42 | +0.65% |
American Funds Washington Mutual C | |||
JDVAX | 16.89 | 0.07 | +0.42% |
JPMorgan Diversified A |